{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:16:18Z","timestamp":1765523778229,"version":"3.48.0"},"reference-count":0,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Meeting report of the \u201cSecond Symposium on Pharmacology of Cytochrome P450 and Transporters\u201d organized by the Cuban Society of Pharmacology in collaboration with the European Society of Pharmacogenetics and Theranostics (ESPT) and the Ibero-American Network of Pharmacogenetics and Pharmacogenomics (www.ribef.com). The Symposium covered different topics on pharmacogenetics and its clinical implications, focusing on Latin-American populations. The activities of the ESPT were also presented and discussed. The topics addressed were regulatory aspects, the use of pharmacogenetics in pre-clinical research, herbal medicine, and natural products, ending with a discussion about translation into clinical practice, specifically for cardiovascular disorders and psychiatry. Finally, the implication for population diversity in Latin America was also discussed. The RIBEF initiative represents a promising step towards the inclusion of Latin American populations among those to benefit from the implementation of pharmacogenetics in clinical practice. Among current RIBEF activities, the CEIBA.FP Consortium aims to study the variability of pheno- and genotypes in Hispanics that are relevant to pharmacogenetics. For this purpose, populations from Mexico, Cuba, Nicaragua, Costa Rica, Ecuador, Colombia, Brasil, Per\u00fa, Chile, Uruguay, Argentina, Portugal, and Spain are currently being studied. The meeting\u2019s main conclusion was that population pharmacogenetic studies as well as academic clinical trials might need to be conducted in the different geographic locations\/countries. This is important in order to improve drug safety, dosage recommendations, and pharmacovigilance programs, because environmental and ethnic factors vary across locations.<\/jats:p>\n                    <jats:fn-group>\n                      <jats:fn id=\"fn1_w2aab3b8c15b1b7b1aab1c14b2aAa\">\n                        <jats:label>a<\/jats:label>\n                        <jats:p>\n                          The following members, constitute the \u201cC\n                          <jats:italic>EIBA.FP Consorcio Europeo Ibero-Americano de Farmacogen\u00e9tica de Poblaciones\/European Ibero Latino American Consortium of Population Pharmacogenetics<\/jats:italic>\n                          \u201d (*Group Coordinator):\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 01:<\/jats:bold>\n                          Authors: Graciela E. Moya*; Ver\u00f3nica Ferrero. Institutions: UCA Pontificia Universidad Cat\u00f3lica Argentina and Fundaci\u00f3n GENOS, Buenos Aires, Argentina.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 02:<\/jats:bold>\n                          Authors: Eduardo Tarazona-Santos*. Institutions: UFMG Universidade Federal de Mina Gerais, Belohorizonte, Brasil and PRISMA Association, Lima, Per\u00fa.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 03:<\/jats:bold>\n                          Authors: Jenny Fiedler1,*; Luisa Herrera\n                          <jats:sup>1<\/jats:sup>\n                          ; Romina Rojas-Ponce\n                          <jats:sup>2<\/jats:sup>\n                          . Institutions:\n                          <jats:sup>1<\/jats:sup>\n                          UCH Uuniversidad de Chile, Santiago and\n                          <jats:sup>2<\/jats:sup>\n                          UCON Universidad de Concepci\u00f3n, Concepci\u00f3n, Chile.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 04:<\/jats:bold>\n                          Authors: Alba P. Sarmiento-S\u00e1nchez*; Ang\u00e9lica Borb\u00f3n-Orejuela. Institution: PUJ Pontificia Universidad Javeriana, Bogot\u00e1, Colombia.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 05:<\/jats:bold>\n                          Authors: Ramiro Barrantes*; Gerardo Jim\u00e9nez-Arce; Carolina C\u00e9spedes. Institution: UCR Universidad de Costa Rica, San Jos\u00e9, Costa Rica.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 06:<\/jats:bold>\n                          Authors: Idania Rodeiro1,2,*; Mayra \u00c1lvarez\n                          <jats:sup>2<\/jats:sup>\n                          ; B\u00e1rbaro P\u00e9rez\n                          <jats:sup>2<\/jats:sup>\n                          ; Luis Calzadilla\n                          <jats:sup>3<\/jats:sup>\n                          ; Ren\u00e9 Delgado\n                          <jats:sup>4<\/jats:sup>\n                          ; Diadelis Remirez\n                          <jats:sup>5<\/jats:sup>\n                          . Institutions:\n                          <jats:sup>1<\/jats:sup>\n                          CEBIMAR,\n                          <jats:sup>2<\/jats:sup>\n                          Facultad de Medicina Calixto Garc\u00eda,\n                          <jats:sup>3<\/jats:sup>\n                          Centro Comunitario de Salud Mental La Habana Vieja,\n                          <jats:sup>4<\/jats:sup>\n                          Centro para las Investigaciones y Desarrollo de los Medicamentos, CIDEM,\n                          <jats:sup>5<\/jats:sup>\n                          Centro Estatal para el Control y Calidad de los Medicamentos, CEMED, Havana, Cuba.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 07:<\/jats:bold>\n                          Authors: Enrique Ter\u00e1n\n                          <jats:sup>1,2,<\/jats:sup>\n                          *; Natalia Heras\n                          <jats:sup>2<\/jats:sup>\n                          ; Leonardo Beltr\u00e1n\n                          <jats:sup>2<\/jats:sup>\n                          ; Francisco Hern\u00e1nez\n                          <jats:sup>3<\/jats:sup>\n                          . Institutions: 1USFQ Universidad San Francisco de Quito, 2UCE Universidad Central de Ecuador Quito, 3UG Universidad Estatal de Guayaquil, Ecuador.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 08:<\/jats:bold>\n                          Authors: Adri\u00e1n LLerena*; Pedro Dorado; Eva M. Pe\u00f1as-Lled\u00f3; Jes\u00fas Cobaleda; M. Eugenia Gonz\u00e1lez-Naranjo; Fernando de Andr\u00e9s. Institution: UEX University of Extremadura, Badajoz, Spain.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 09:<\/jats:bold>\n                          Authors: Roc\u00edo Ortiz-L\u00f3pez*; Augusto Rojas-Mart\u00ednez; Lourdes Garza-Oca\u00f1as; Yadira X. P\u00e9rez-P\u00e1ramo. Institution: UAN Universidad Aut\u00f3noma de Nuevo Le\u00f3n, Monterrey, Nuevo Le\u00f3n, M\u00e9xico.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 10:<\/jats:bold>\n                          Authors: Marisol L\u00f3pez-L\u00f3pez\n                          <jats:sup>1,<\/jats:sup>\n                          *; Alberto Ortega-V\u00e1zquez\n                          <jats:sup>1<\/jats:sup>\n                          ; Elisa Alonso-Vilatela\n                          <jats:sup>2<\/jats:sup>\n                          ; Nancy Monroy-Jaramillo\n                          <jats:sup>2<\/jats:sup>\n                          ; Teresa Corona V\u00e1zquez\n                          <jats:sup>2<\/jats:sup>\n                          ; Petra Yescas-G\u00f3mez\n                          <jats:sup>2<\/jats:sup>\n                          ; Adriana Ochoa-Morales\n                          <jats:sup>2<\/jats:sup>\n                          ; Institutions:\n                          <jats:sup>1<\/jats:sup>\n                          UAM Universidad Aut\u00f3noma Metropolitana and\n                          <jats:sup>2<\/jats:sup>\n                          Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda Manuel Velasco Su\u00e1rez, M\u00e9xico DF, M\u00e9xico.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 11:<\/jats:bold>\n                          Authors: Martha G. Sosa-Mac\u00edas*; Carlos Galaviz-Hern\u00e1ndez; Ismael Lares; Blanca Lazalde. Institution: IPN Instituto Polit\u00e9cnico Nacional-CIIDIR, Durango, M\u00e9xico.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 12<\/jats:bold>\n                          <jats:italic>:<\/jats:italic>\n                          Authors: Ronald Ramirez-Roa*. Institution: UNAN Universidad Nacional Aut\u00f3noma de Nicaragua, Le\u00f3n, Nicaragua.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 13:<\/jats:bold>\n                          Authors: Manuela Grazina*. Institution: UC.PT University of Coimbra, Portugal.\n                        <\/jats:p>\n                        <jats:p>\n                          <jats:bold>Group 14:<\/jats:bold>\n                          Authors: Francisco E. Est\u00e9vez-Carrizo*; Nicol\u00e1s Gonz\u00e1lez-Vacarezza. Institution: UM Universidad de Montevideo, Uruguay.\n                        <\/jats:p>\n                      <\/jats:fn>\n                    <\/jats:fn-group>\n                  <\/jats:sec>","DOI":"10.1515\/dmdi-2012-0006","type":"journal-article","created":{"date-parts":[[2012,3,22]],"date-time":"2012-03-22T05:56:39Z","timestamp":1332395799000},"page":"57-60","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacogenetics in Latin American populations: regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders"],"prefix":"10.1515","volume":"27","author":[{"given":"Idania","family":"Rodeiro","sequence":"first","affiliation":[]},{"given":"Diadelis","family":"Rem\u00edrez-Figueredo","sequence":"additional","affiliation":[]},{"given":"Milagros","family":"Garc\u00eda-Mesa","sequence":"additional","affiliation":[{"name":"National Institute for Angiology and Vascular Surgery, Havana, Cuba"}]},{"given":"Pedro","family":"Dorado","sequence":"additional","affiliation":[]},{"given":"Adri\u00e1n","family":"LLerena","sequence":"additional","affiliation":[]}],"member":"374","published-online":{"date-parts":[[2012,3,1]]},"container-title":["dmdi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dmdi-2012-0006\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dmdi-2012-0006\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:11:32Z","timestamp":1765523492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dmdi-2012-0006\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,3,2]]},"published-print":{"date-parts":[[2012,3,1]]}},"alternative-id":["10.1515\/dmdi-2012-0006"],"URL":"https:\/\/doi.org\/10.1515\/dmdi-2012-0006","relation":{},"ISSN":["2191-0162","0792-5077"],"issn-type":[{"type":"electronic","value":"2191-0162"},{"type":"print","value":"0792-5077"}],"subject":[],"published":{"date-parts":[[2012,3,1]]}}}